Exagen (XGN) Amortization of Deferred Charges (2018 - 2026)
Exagen (XGN) posted Amortization of Deferred Charges of $133000.0 for Q1 2026, up 1.53% quarter-over-quarter from $131000.0 in Q4 2025, and up 216.67% year-on-year from $42000.0 in Q1 2025.
Exagen (XGN) Amortization of Deferred Charges (2018 - 2026) Analysis & Trends
Exagen (XGN) has reported Amortization of Deferred Charges for 9 consecutive years, with $133000.0 the latest figure, recorded in Q1 2026.
- Amortization of Deferred Charges for Q1 2026 came in at $133000.0, up 216.67% year-over-year; the trailing twelve-month figure through Mar 2026 was $469000.0 (up 194.97% YoY), and the FY2025 annual result was $378000.0, up 145.45% from the prior year.
- Amortization of Deferred Charges was $133000.0 for Q1 2026 at Exagen, up from $131000.0 in the prior quarter.
- Over five years, Amortization of Deferred Charges peaked at $333000.0 in Q3 2022 and troughed at -$25000.0 in Q3 2024.
- Average Amortization of Deferred Charges over 5 years is $92882.4, with a median of $79000.0 recorded in 2025.
- Year-over-year, Amortization of Deferred Charges soared 932.5% in 2022 and tumbled 136.76% in 2024.
- Over 5 years, Amortization of Deferred Charges stood at $140000.0 in 2022, then slumped by 50.71% to $69000.0 in 2023, then plunged by 39.13% to $42000.0 in 2024, then soared by 211.9% to $131000.0 in 2025, then grew by 1.53% to $133000.0 in 2026.
- Per Business Quant data, the three most recent Amortization of Deferred Charges figures were $133000.0 in Q1 2026, $131000.0 in Q4 2025, and $126000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Waters | 31,055.11 Bn | 31,054.65 Bn | 1.11 Bn |
| 2 | Thermo Fisher Scientific | 191.02 Bn | 187.77 Bn | 7.74 Bn |
| 3 | Danaher | 137.16 Bn | 131.47 Bn | 3.59 Bn |
| 4 | Idexx Laboratories | 42.82 Bn | 42.62 Bn | 722.74 Mn |
| 5 | Natera | 39.09 Bn | 37.99 Bn | 696.04 Mn |
| 6 | Agilent Technologies | 37.61 Bn | 35.81 Bn | 990.00 Mn |
| 7 | Iqvia Holdings | 34.23 Bn | 32.25 Bn | 1.36 Bn |
| 8 | Illumina | 28.14 Bn | 26.98 Bn | 721.00 Mn |
| 9 | Mettler Toledo International | 26.40 Bn | 26.33 Bn | 555.82 Mn |
| 10 | Exagen | 112.36 Mn | 90.84 Mn | 10.21 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 133,000.00 |
| Mar 31, 2026 | 133,000.00 |
| Dec 31, 2025 | 131,000.00 |
| Dec 31, 2025 | 131,000.00 |
| Sep 30, 2025 | 126,000.00 |
| Sep 30, 2025 | 126,000.00 |
| Jun 30, 2025 | 79,000.00 |
| Jun 30, 2025 | 79,000.00 |
| Mar 31, 2025 | 42,000.00 |
| Mar 31, 2025 | 42,000.00 |
| Dec 31, 2024 | 42,000.00 |
| Dec 31, 2024 | 42,000.00 |
| Sep 30, 2024 | -25,000.00 |
| Sep 30, 2024 | -25,000.00 |
| Jun 30, 2024 | 100,000.00 |
| Jun 30, 2024 | 100,000.00 |
| Mar 31, 2024 | 37,000.00 |
| Mar 31, 2024 | 37,000.00 |
| Dec 31, 2023 | 69,000.00 |
| Dec 31, 2023 | 69,000.00 |